Fig. 1From: Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 databasePatient flow diagram in the cross-sectional and longitudinal cohorts. AD Alzheimer’s disease, MCI Mild cognitive impairment, SMC Significant memory complaintBack to article page